Mabion S.A. (WSE:MAB)
Poland · Delayed Price · Currency is PLN 8.57
-0.12 (-1.38%)
Oct 10, 2025, 5:00 PM CET
Mabion Market Cap
Mabion has a market cap or net worth of 138.51 million as of October 10, 2025. Its market cap has decreased by -48.31% in one year.
Market Cap
138.51M
Enterprise Value
131.08M
Revenue
11.24M
Ranking
n/a
PE Ratio
n/a
Stock Price
8.57
Market Cap Chart
Since August 10, 2010, Mabion's market cap has increased from 93.01M to 138.51M, an increase of 48.92%. That is a compound annual growth rate of 2.66%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 10, 2025 | 138.51M | -3.71% |
| Dec 30, 2024 | 143.84M | -50.96% |
| Dec 29, 2023 | 293.35M | -13.57% |
| Dec 30, 2022 | 339.41M | -65.63% |
| Dec 30, 2021 | 987.46M | 246.59% |
| Dec 30, 2020 | 284.90M | -73.03% |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Diagnostyka | 6.11B |
| NEUCA | 3.22B |
| Synektik Spólka Akcyjna | 2.27B |
| Voxel | 1.85B |
| Celon Pharma | 1.22B |
| Selvita | 662.63M |
| Centrum Medyczne ENEL-MED | 523.19M |
| Ryvu Therapeutics | 491.93M |